ArticleCPT: pharmacometrics & systems pharmacology2022

Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer.

Anne-Gaëlle Dosne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.